Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline in Comorbid Obesity and Depression
NCT06537921Recruiting
- Sponsor
- King's College London
- Start
- Oct 2024
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of minocycline in major depressive disorder (MDD), sponsored by King's College London. Primary endpoints: Enrolment rate, Intervention adherence at 8 weeks and 2 more. Started Oct 2024; status: recruiting.
02
Drugs
minocycline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06537921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06537921.